Reta + Cagri
This product is a triple agonist designed to activate GLP-1, GIP, and Glucagon receptors, adding Cagri for amylin signaling.
- The description claims to increase effects through four pathways.
Specifications
- Size
- Reta 10mg + Cagri 10mg, Reta 20mg + Cagri 10mg, Reta 30mg + Cagri 10mg, Reta 50mg + Cagri 10mg
Variants (4)
- Reta 10mg + Cagri 10mg — 145.00 GBP — In stock
- Reta 20mg + Cagri 10mg — 205.00 GBP — In stock
- Reta 30mg + Cagri 10mg — 260.00 GBP — In stock
- Reta 50mg + Cagri 10mg — 340.00 GBP — In stock
AI Readiness
Good foundation, but some important product data is still missing.
68%